HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-NOV-12 4I6F TITLE SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT TITLE 2 REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PLK2 KINASE DOMAIN; COMPND 5 SYNONYM: POLO-LIKE KINASE 2, PLK-2, HPLK2, SERINE/THREONINE-PROTEIN COMPND 6 KINASE SNK, HSNK, SERUM-INDUCIBLE KINASE; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK2, SNK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS POLO-LIKE KINASE-2 (PLK-2), SYNUCLEIN, PARKINSONS DISEASE, KINASE KEYWDS 2 INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.PAN REVDAT 2 28-FEB-24 4I6F 1 REMARK SEQADV REVDAT 1 20-NOV-13 4I6F 0 JRNL AUTH D.L.AUBELE,R.K.HOM,M.ADLER,R.A.GALEMMO,S.BOWERS,A.P.TRUONG, JRNL AUTH 2 H.PAN,P.BEROZA,R.J.NEITZ,N.YAO,M.LIN,G.TONN,H.ZHANG, JRNL AUTH 3 M.P.BOVA,Z.REN,D.TAM,L.RUSLIM,J.BAKER,L.DIEP,K.FITZGERALD, JRNL AUTH 4 J.HOFFMAN,R.MOTTER,D.FAUSS,P.TANAKA,M.DAPPEN,J.JAGODZINSKI, JRNL AUTH 5 W.CHAN,A.W.KONRADI,L.LATIMER,Y.L.ZHU,H.L.SHAM,J.P.ANDERSON, JRNL AUTH 6 M.BERGERON,D.R.ARTIS JRNL TITL SELECTIVE AND BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) JRNL TITL 2 INHIBITORS THAT REDUCE ALPHA-SYNUCLEIN PHOSPHORYLATION IN JRNL TITL 3 RAT BRAIN. JRNL REF CHEMMEDCHEM V. 8 1295 2013 JRNL REFN ISSN 1860-7179 JRNL PMID 23794260 JRNL DOI 10.1002/CMDC.201300166 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 6709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.321 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 333 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 500 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 29 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2333 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.14000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.602 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.509 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 25.801 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.902 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.802 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2433 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3286 ; 1.840 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 286 ; 6.535 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 115 ;33.736 ;22.261 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 439 ;20.879 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;18.599 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 351 ; 0.117 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1841 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1427 ; 0.629 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2317 ; 1.189 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1006 ; 1.510 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 968 ; 2.513 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4I6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-12. REMARK 100 THE DEPOSITION ID IS D_1000076362. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9788 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6709 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 33.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS, 0.8 M SODIUM FORMATE, REMARK 280 19% PEG 3350, PH 5.5, EVAPORATION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.91200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.06150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.91200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.06150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 53 REMARK 465 MET A 54 REMARK 465 HIS A 55 REMARK 465 HIS A 56 REMARK 465 HIS A 57 REMARK 465 HIS A 58 REMARK 465 HIS A 59 REMARK 465 HIS A 60 REMARK 465 HIS A 61 REMARK 465 HIS A 62 REMARK 465 SER A 63 REMARK 465 HIS A 64 REMARK 465 SER A 65 REMARK 465 GLY A 66 REMARK 465 PRO A 67 REMARK 465 GLU A 68 REMARK 465 ILE A 69 REMARK 465 SER A 70 REMARK 465 LEU A 356 REMARK 465 SER A 357 REMARK 465 SER A 358 REMARK 465 PRO A 359 REMARK 465 ALA A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP A 75 O THR A 78 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 233 CA - CB - CG ANGL. DEV. = 16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 146 -74.44 -97.55 REMARK 500 CYS A 162 73.68 -111.54 REMARK 500 ARG A 165 -121.64 64.70 REMARK 500 LYS A 175 -54.08 74.49 REMARK 500 ASP A 205 38.17 -150.38 REMARK 500 ASP A 223 77.31 46.65 REMARK 500 PHE A 224 46.70 -93.62 REMARK 500 LYS A 254 76.85 45.89 REMARK 500 LEU A 315 40.97 -98.60 REMARK 500 PHE A 333 -39.77 -39.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 79 LYS A 80 -34.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1C7 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4I6B RELATED DB: PDB REMARK 900 RELATED ID: 4I6H RELATED DB: PDB REMARK 900 RELATED ID: 4I5M RELATED DB: PDB REMARK 900 RELATED ID: 4I5P RELATED DB: PDB DBREF 4I6F A 57 360 UNP Q9NYY3 PLK2_HUMAN 57 360 SEQADV 4I6F MET A 53 UNP Q9NYY3 INITIATING METHIONINE SEQADV 4I6F MET A 54 UNP Q9NYY3 EXPRESSION TAG SEQADV 4I6F HIS A 55 UNP Q9NYY3 EXPRESSION TAG SEQADV 4I6F HIS A 56 UNP Q9NYY3 EXPRESSION TAG SEQADV 4I6F SER A 83 UNP Q9NYY3 CYS 83 ENGINEERED MUTATION SEQADV 4I6F THR A 87 UNP Q9NYY3 VAL 87 ENGINEERED MUTATION SEQADV 4I6F SER A 119 UNP Q9NYY3 ALA 119 ENGINEERED MUTATION SEQADV 4I6F SER A 216 UNP Q9NYY3 ALA 216 ENGINEERED MUTATION SEQADV 4I6F ALA A 259 UNP Q9NYY3 CYS 259 ENGINEERED MUTATION SEQADV 4I6F SER A 291 UNP Q9NYY3 CYS 291 ENGINEERED MUTATION SEQADV 4I6F THR A 335 UNP Q9NYY3 LEU 335 ENGINEERED MUTATION SEQRES 1 A 308 MET MET HIS HIS HIS HIS HIS HIS HIS HIS SER HIS SER SEQRES 2 A 308 GLY PRO GLU ILE SER ARG ILE ILE VAL ASP PRO THR THR SEQRES 3 A 308 GLY LYS ARG TYR SER ARG GLY LYS THR LEU GLY LYS GLY SEQRES 4 A 308 GLY PHE ALA LYS CYS TYR GLU MET THR ASP LEU THR ASN SEQRES 5 A 308 ASN LYS VAL TYR ALA ALA LYS ILE ILE PRO HIS SER ARG SEQRES 6 A 308 VAL SER LYS PRO HIS GLN ARG GLU LYS ILE ASP LYS GLU SEQRES 7 A 308 ILE GLU LEU HIS ARG ILE LEU HIS HIS LYS HIS VAL VAL SEQRES 8 A 308 GLN PHE TYR HIS TYR PHE GLU ASP LYS GLU ASN ILE TYR SEQRES 9 A 308 ILE LEU LEU GLU TYR CYS SER ARG ARG SER MET ALA HIS SEQRES 10 A 308 ILE LEU LYS ALA ARG LYS VAL LEU THR GLU PRO GLU VAL SEQRES 11 A 308 ARG TYR TYR LEU ARG GLN ILE VAL SER GLY LEU LYS TYR SEQRES 12 A 308 LEU HIS GLU GLN GLU ILE LEU HIS ARG ASP LEU LYS LEU SEQRES 13 A 308 GLY ASN PHE PHE ILE ASN GLU SER MET GLU LEU LYS VAL SEQRES 14 A 308 GLY ASP PHE GLY LEU ALA ALA ARG LEU GLU PRO LEU GLU SEQRES 15 A 308 HIS ARG ARG ARG THR ILE CYS GLY THR PRO ASN TYR LEU SEQRES 16 A 308 SER PRO GLU VAL LEU ASN LYS GLN GLY HIS GLY ALA GLU SEQRES 17 A 308 SER ASP ILE TRP ALA LEU GLY CYS VAL MET TYR THR MET SEQRES 18 A 308 LEU LEU GLY ARG PRO PRO PHE GLU THR THR ASN LEU LYS SEQRES 19 A 308 GLU THR TYR ARG SER ILE ARG GLU ALA ARG TYR THR MET SEQRES 20 A 308 PRO SER SER LEU LEU ALA PRO ALA LYS HIS LEU ILE ALA SEQRES 21 A 308 SER MET LEU SER LYS ASN PRO GLU ASP ARG PRO SER LEU SEQRES 22 A 308 ASP ASP ILE ILE ARG HIS ASP PHE PHE THR GLN GLY PHE SEQRES 23 A 308 THR PRO ASP ARG LEU SER SER SER CYS CYS HIS THR VAL SEQRES 24 A 308 PRO ASP PHE HIS LEU SER SER PRO ALA HET 1C7 A 401 30 HETNAM 1C7 (7R)-8-CYCLOPENTYL-7-ETHYL-5-METHYL-2-(2-PHENYL-1H- HETNAM 2 1C7 IMIDAZOL-1-YL)-7,8-DIHYDROPTERIDIN-6(5H)-ONE FORMUL 2 1C7 C23 H26 N6 O FORMUL 3 HOH *36(H2 O) HELIX 1 1 SER A 116 VAL A 118 5 3 HELIX 2 2 LYS A 120 ARG A 135 1 16 HELIX 3 3 SER A 166 LYS A 175 1 10 HELIX 4 4 THR A 178 GLN A 199 1 22 HELIX 5 5 LYS A 207 GLY A 209 5 3 HELIX 6 6 ASP A 223 ALA A 227 5 5 HELIX 7 7 SER A 248 ASN A 253 1 6 HELIX 8 8 GLY A 258 GLY A 276 1 19 HELIX 9 9 LEU A 285 GLU A 287 5 3 HELIX 10 10 THR A 288 ALA A 295 1 8 HELIX 11 11 LEU A 304 LEU A 315 1 12 HELIX 12 12 ASN A 318 ARG A 322 5 5 HELIX 13 13 SER A 324 ARG A 330 1 7 HELIX 14 14 HIS A 331 GLN A 336 1 6 HELIX 15 15 SER A 345 HIS A 349 5 5 SHEET 1 A 6 ILE A 72 VAL A 74 0 SHEET 2 A 6 ARG A 81 GLY A 91 -1 O TYR A 82 N ILE A 73 SHEET 3 A 6 ALA A 94 ASP A 101 -1 O THR A 100 N SER A 83 SHEET 4 A 6 VAL A 107 PRO A 114 -1 O ALA A 110 N TYR A 97 SHEET 5 A 6 ASN A 154 GLU A 160 -1 O ILE A 155 N ILE A 113 SHEET 6 A 6 PHE A 145 GLU A 150 -1 N PHE A 149 O TYR A 156 SHEET 1 B 2 ILE A 201 LEU A 202 0 SHEET 2 B 2 ALA A 228 ARG A 229 -1 O ALA A 228 N LEU A 202 SHEET 1 C 2 PHE A 211 ILE A 213 0 SHEET 2 C 2 LEU A 219 VAL A 221 -1 O LYS A 220 N PHE A 212 SITE 1 AC1 9 CYS A 96 ALA A 109 VAL A 143 LEU A 159 SITE 2 AC1 9 GLU A 160 TYR A 161 CYS A 162 HIS A 169 SITE 3 AC1 9 PHE A 212 CRYST1 103.824 60.123 53.119 90.00 107.14 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009632 0.000000 0.002970 0.00000 SCALE2 0.000000 0.016633 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019700 0.00000